glp-1 agonists with cardiovascular benefit Bridging the gap between GLP1-receptor and outcomes: evidence for the role of tirzepatide | Cardiovascular Diabetology Discover the Game-Changing Benefits of
Description
[46] By upregulating proteins like parkin and TFEB, semaglutide enhances the clearance of damaged organelles
Wegovy (semaglutide) [package insert]
[Google Scholar] 109
95% CI 31.99 to 7.03
Because they're classed as food supplements rather than medicines, they don't go through the same rigorous clinical testing, safety reviews, or approval processes that prescription treatments like Mounjaro and Wegovy do
